An “electronic nose” may one day be used to diagnose asthma, say researchers who are presenting a preliminary study of the device at the American Thoracic Society 2007 International Conference, on Monday, May 21.
Extremely drug resistant TB, or XDR-TB, is a serious problem in India, according to a study presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.
The use of peginterferon alone, or in combination with ribavirin, points to a cure for hepatitis C, the leading cause of cirrhosis, liver cancer and the need for liver transplant, a Virginia Commonwealth University researcher said today.
Marijuana worsens breathing problems in current smokers with chronic obstructive pulmonary disease (COPD), according to a study presented at the American Thoracic Society 2007 International Conference, on Tuesday, May 22.
National Jewishm Medical and Research Center faculty present research on asthma and obesity — asthma, perception vs. reality — salmeterol — asthma and air pollution — cleaning up allergens.
A new study of intensive care unit patients who are breathing with the help of a mechanical ventilator has found that a two-step sedation and ventilator weaning protocol?called a ?wake up and breathe? strategy?helps patients come off the ventilator faster so that they can be discharged from the ICU and hospital more quickly.
Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist? (formoterol fumarate) Inhalation Solution, delivered by nebulization, is an effective and well-tolerated new treatment option for patients suffering from emphysema or chronic bronchitis, otherwise known as Chronic Obstructive Pulmonary Disease (COPD).
Basic research, or research where the primary goal is the advancement of human knowledge and theoretical understanding, has throughout its history been pressed by politicians and the public to justify its existence.
The biotechnology company Alimentary Health today announced results from two studies that demonstrate the anti-inflammatory activity of a natural probiotic bacterial strain of human origin, Bifantis? (Bifidobacterium infantis 35624), in models of arthritis and Salmonella infection.
Drug delivery systems have progressed from the teaspoon to time-release capsules to drug-eluting stents.